Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/45342
Title: Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action [version 1; referees: 2 approved, 1 approved with reservations]
Authors: Sharon J. Peacock
Keiji Fukuda
Direk Limmathurotsakul
Iruka N. Okeke
Nandini Shetty
Rogier van Doorn
Nicholas A. Feasey
Francesca Chiara
Ghada Zoubiane
Tim Jinks
Julian Parkhill
Jean Patel
Stuart W.J. Reid
Alison H. Holmes
Public Health England
The University of Hong Kong Li Ka Shing Faculty of Medicine
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
London School of Hygiene & Tropical Medicine
Royal Veterinary College University of London
Wellcome Trust
Centers for Disease Control and Prevention
Imperial College London
Mahidol University
University of Ibadan
Wellcome Sanger Institute
Oxford University Clinical Research Unit
Keywords: Biochemistry, Genetics and Molecular Biology;Medicine
Issue Date: 1-Jan-2018
Citation: Wellcome Open Research. Vol.3, (2018)
Abstract: © 2018 Fukuda K et al. In recognition of the central importance of surveillance and epidemiology in the control of antimicrobial resistance and the need to strengthen surveillance at all levels, Wellcome has brought together a new international expert group SEDRIC (Surveillance and Epidemiology of Drug Resistant Infections Consortium). SEDRIC aims to advance and transform the ways of tracking, sharing and analysing rates of infection and drug resistance, burden of disease, information on antibiotic use, opportunities for preventative measures such as vaccines, and contamination of the environment. SEDRIC will strengthen the availability of information needed to monitor and track risks, including an evaluation of access to, and utility of data generated by pharma and research activities, and will support the translation of surveillance data into interventions, changes in policy and more effective practices. Ways of working will include the provision of independent scientific analysis, advocacy and expert advice to groups, such as the Wellcome Drug Resistant Infection Priority Programme. A priority for SEDRIC's first Working Group is to review mechanisms to strengthen the generation, collection, collation and dissemination of high quality data, together with the need for creativity in the use of existing data and proxy measures, and linking to existing in-country networking infrastructure. SEDRIC will also promote the translation of technological innovations into public health solutions.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85048270103&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/45342
ISSN: 2398502X
Appears in Collections:Scopus 2018

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.